« Back
Home /
Strontium ranelate

Strontium ranelate

Item no.	TMO-T1641-500mg
Manufacturer	TargetMol
CASRN	135459-87-9
Amount	500mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Kirschneck C, et al. Eur J Pharmacol. 2014 Dec 5;744:67-75.
Smiles	[Sr+2].c1(c(c(c(s1)N(CC(=O)[O-])CC(=O)[O-])C#N)CC(=O)[O-])C(=O)[O-].[Sr+2]
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Calcium Channel inhibitor, Distrontium renelate , S12911
Available
Short Description	Strontium ranelate (S12911), a strontium (II) salt of the ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in the treatment of severe osteoporosis.
Shipping	cool pack
Storage	-20°
Target names or alias	Distrontium renelate , S12911
Molecular Weight	513, 49
Pathway	Membrane transporter/Ion channel\|\|\|Metabolism\|\|\|GPCR/G Protein
Target	CaSR\|\|\|Calcium Channel

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail